NAMS
NewAmsterdam Pharma·NASDAQ
--
--(--)
--
--(--)
Latest data update time: Updated on 2026-01-31
Latest data update time: Updated on 2026-01-31
4.39 / 10Overall Score
NeturalInvestment Rating
4.39 / 10Overall Score
NeturalInvestment Rating
Trend Analysis of NAMS
- Based on a composite score of 4.39/10, we rate NAMS as a Netural. Our analysis breaks down into 2.49/10 for Fundamentals, 3.72/10 for Technicals, and 5.67/10 for Sentiment, indicating the stock is likely to consolidate sideways.
Technical Analysis of NAMS?
Is NAMS undervalued or overvalued?
Is money flowing into or out of NAMS?
Trend Analysis of NAMS
- Based on a composite score of 4.39/10, we rate NAMS as a Netural. Our analysis breaks down into 2.49/10 for Fundamentals, 3.72/10 for Technicals, and 5.67/10 for Sentiment, indicating the stock is likely to consolidate sideways.
Is NAMS undervalued or overvalued?
Technical Analysis of NAMS?
Is money flowing into or out of NAMS?
